Elevated γ-Glutamyltransferase serum levels are associated with increased risk of overall cancer incidence and several site-specific malignancies. In the present prospective study we report on the associations of serum γ-Glutamyltransferase with the risk of breast cancer in a pooled population-based cohort considering established life style risk factors.Two cohorts were included in the present study, i.e. the Vorarlberg (n = 97,268) and the Malmoe cohort (n = 9,790). Cox proportional hazards regression models were fitted to estimate HRs for risk of breast cancer.In multivariate analysis adjusted for age, body mass index and smoking status, women with γ-Glutamyltransferase levels in the top quartile were at significantly higher risk for brea...
Impaired glucose metabolism has been linked with increased cancer risk, but the association between ...
In clinical practice, increased serum g-glutamyltransferase (GGT) activity is usually interpreted as...
Known modifiable risk factors account for a small fraction of premenopausal breast cancers. We inves...
Elevated γ-Glutamyltransferase serum levels are associated with increased risk of overall cancer inc...
Objective: Elevated γ-Glutamyltransferase serum levels are associated with increased risk of overall...
Elevated serum γ-glutamyltransferase (GGT) is a marker of hepatic injury and is associated with risk...
The prospective evidence for the associations of gamma glutamyltransferase (GGT) and alanine aminotr...
The prospective evidence for the associations of gamma glutamyltransferase (GGT) and alanine aminotr...
BACKGROUND: Different etiological pathways may precede development of specific breast cancer subtype...
Gamma-glutamyltransferase (GGT) is a marker for hepatic injury and alcohol consumption. However, the...
To study the association of γ-glutamyltransferase (GGT) with the development of the metabolic syndro...
Emerging evidence that an elevated serum gamma-glutamyltransferase (GGT) level is associated with an...
Background: Metabolomics is a promising molecular tool for identifying novel etiological pathways le...
Background: Metabolomics is a promising molecular tool for identifying novel etiological pathways le...
International audiencePurpose: Breast cancer is a major cause of death in occidental women. Mechanis...
Impaired glucose metabolism has been linked with increased cancer risk, but the association between ...
In clinical practice, increased serum g-glutamyltransferase (GGT) activity is usually interpreted as...
Known modifiable risk factors account for a small fraction of premenopausal breast cancers. We inves...
Elevated γ-Glutamyltransferase serum levels are associated with increased risk of overall cancer inc...
Objective: Elevated γ-Glutamyltransferase serum levels are associated with increased risk of overall...
Elevated serum γ-glutamyltransferase (GGT) is a marker of hepatic injury and is associated with risk...
The prospective evidence for the associations of gamma glutamyltransferase (GGT) and alanine aminotr...
The prospective evidence for the associations of gamma glutamyltransferase (GGT) and alanine aminotr...
BACKGROUND: Different etiological pathways may precede development of specific breast cancer subtype...
Gamma-glutamyltransferase (GGT) is a marker for hepatic injury and alcohol consumption. However, the...
To study the association of γ-glutamyltransferase (GGT) with the development of the metabolic syndro...
Emerging evidence that an elevated serum gamma-glutamyltransferase (GGT) level is associated with an...
Background: Metabolomics is a promising molecular tool for identifying novel etiological pathways le...
Background: Metabolomics is a promising molecular tool for identifying novel etiological pathways le...
International audiencePurpose: Breast cancer is a major cause of death in occidental women. Mechanis...
Impaired glucose metabolism has been linked with increased cancer risk, but the association between ...
In clinical practice, increased serum g-glutamyltransferase (GGT) activity is usually interpreted as...
Known modifiable risk factors account for a small fraction of premenopausal breast cancers. We inves...